in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy. Am Heart J. 2005 Apr;149(4):744-50. \[[PubMed: 15990762](https://pubmed.ncbi.nlm.nih.gov/15990762)\] 39. Bayes-Genis A, Lloyd-Jones DM, van Kimmenade RR, Lainchbury JG, Richards AM, Ordoñez-Llanos J, Santaló M, Pinto YM, Januzzi JL. Effect of body mass index on diagnostic and prognostic usefulness of amino-terminal pro-brain natriuretic peptide in patients with acute dyspnea. Arch Intern Med. 2007 Feb 26;167(4):400-7. \[[PubMed: 17325303](https://pubmed.ncbi.nlm.nih.gov/17325303)\] 40. Semenov AG, Feygina EE. Standardization of BNP and NT-proBNP Immunoassays in Light of the Diverse and Complex Nature of Circulating BNP-Related Peptides. Adv Clin Chem. 2018;85:1-30. \[[PubMed: 29655458](https://pubmed.ncbi.nlm.nih.gov/29655458)\] 41. Tamm NN, Seferian KR, Semenov AG, Mukharyamova KS, Koshkina EV, Krasnoselsky MI, Postnikov AB, Serebryanaya DV, Apple FS, Murakami MM, Katrukha AG. Novel immunoassay for quantification of brain natriuretic peptide and its precursor in human blood. Clin Chem. 2008 Sep;54(9):1511-8. \[[PubMed: 18606632](https://pubmed.ncbi.nlm.nih.gov/18606632)\] 42. Cao Z, Jia Y, Zhu B. BNP and NT-proBNP as Diagnostic Biomarkers for Cardiac Dysfunction in Both Clinical and Forensic Medicine. Int J Mol Sci. 2019 Apr 12;20(8) \[[PMC free article: PMC6515513](/pmc/articles/PMC6515513/)\] \[[PubMed: 31013779](https://pubmed.ncbi.nlm.nih.gov/31013779)\] 43. Weber M, Hamm C. Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine. Heart. 2006 Jun;92(6):843-9. \[[PMC free article: PMC1860679](/pmc/articles/PMC1860679/)\] \[[PubMed: 16698841](https://pubmed.ncbi.nlm.nih.gov/16698841)\] 44. Luckenbill KN, Christenson RH, Jaffe AS, Mair J, Ordonez-Llanos J, Pagani F, Tate J, Wu AH, Ler R, Apple FS. Cross-reactivity of BNP, NT-proBNP, and proBNP in commercial BNP and NT-proBNP assays: preliminary observations from the IFCC Committee for Standardization of Markers of Cardiac Damage. Clin Chem. 2008 Mar;54(3):619-21. \[[PubMed: 18310156](https://pubmed.ncbi.nlm.nih.gov/18310156)\] 45. Clerico A, Fontana M, Zyw L, Passino C, Emdin M. Comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP immunoassays in chronic and acute heart failure: a systematic review. Clin Chem. 2007 May;53(5):813-22. \[[PubMed: 17384013](https://pubmed.ncbi.nlm.nih.gov/17384013)\] 46. Zhang ZL, Li R, Yang FY, Xi L. Natriuretic peptide family as diagnostic/prognostic biomarker and treatment modality in management of adult and geriatric patients with heart failure: remaining issues and challenges. J Geriatr Cardiol. 2018 Aug;15(8):540-546. \[[PMC free article: PMC6188938](/pmc/articles/PMC6188938/)\] \[[PubMed: 30344534](https://pubmed.ncbi.nlm.nih.gov/30344534)\] 47. Saenger AK, Rodriguez-Fraga O, Ler R, Ordonez-Llanos J, Jaffe AS, Goetze JP, Apple FS. Specificity of B-Type Natriuretic Peptide Assays: Cross-Reactivity with Different BNP, NT-proBNP, and proBNP Peptides. Clin Chem. 2017 Jan;63(1):351-358. \[[PubMed: 28062628](https://pubmed.ncbi.nlm.nih.gov/28062628)\] 48. Christ M, Mueller C. Use of natriuretic peptide assay in dyspnea. Dtsch Arztebl Int. 2008 Feb;105(6):95-100. \[[PMC free